-- Roche's Tarceva Fails to Win U.K. Backing as Follow-up Drug in Lung Cancer
-- B y   K r i s t e n   H a l l a m
-- 2010-11-25T00:01:00Z
-- http://www.bloomberg.com/news/2010-11-25/roche-s-tarceva-fails-to-win-u-k-backing-as-follow-up-drug-in-lung-cancer.html
Roche Holding AGâ€™s Tarceva failed to
win the recommendation of the U.K. National Institute for Health
and Clinical Excellence in a second draft of guidelines for non-
small-cell lung cancer.  More evidence is needed before the agency can recommend the
use of Tarceva as a maintenance treatment for patients whose
disease has remained stable following first-line therapy, the
agency said in an e-mailed statement.  To contact the reporter on this story:
 Kristen Hallam  in London at 
 khallam@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at   pserafino@bloomberg.net  